Related Experiment Video
Updated: May 2, 2026
An Efficient and High Yield Method for Isolation of Mouse Dendritic Cell Subsets
Published on: April 18, 2016
Natural killer cells: the secret weapon in dendritic cell vaccination strategies
Catharina H M J Van Elssen1, Tammy Oth, Wilfred T V Germeraad
1Authors' Affiliations: Departments of Internal Medicine, Division of Hematology and Transplantation Immunology, Maastricht University Medical Center, Maastricht, the Netherlands.
Abstract:
In cancer therapy, dendritic cell (DC) vaccination is still being explored. Clinical responses, however, are diverse and there is a lack of immunologic readout systems that correspond with clinical outcome. Only in the minority of patients, T-cell responses correlate with clinical outcome, indicating that other immune cells also gain anticancer activity. We still have limited knowledge of the effect of DC vaccination on different immune effector cells. However, it has been shown that bidirectional cross-talk between natural killer (NK) cells and DCs is responsible for enhanced activation of both cell types and increases their antitumor activity. In this review, we postulate the possibility that NK cells are the secret weapons in DC vaccination and studying their behavior together with T-cell activation in vaccinated individuals might predict clinical outcome.
Insights
Natural killer (NK) cells may be key to dendritic cell (DC) vaccination success in cancer therapy. Monitoring NK cell activity alongside T-cell responses could predict patient outcomes.
Area of Science:
- Immunology
- Cancer Therapy
- Cellular Immunology
Background:
- Dendritic cell (DC) vaccination is an emerging cancer therapy with variable clinical responses.
- Current immunologic readouts, primarily T-cell responses, do not consistently correlate with clinical outcomes.
- The impact of DC vaccination on various immune effector cells remains incompletely understood.
Purpose of the Study:
- To explore the role of natural killer (NK) cells in DC vaccination efficacy.
- To investigate the potential of NK cells as predictive biomarkers for clinical outcomes in DC-vaccinated cancer patients.
- To highlight the importance of studying the interplay between DCs, NK cells, and T cells.
Main Methods:
- Review of existing literature on DC vaccination and immune cell interactions.
- Analysis of the bidirectional cross-talk between dendritic cells and natural killer cells.
- Postulation of NK cell involvement in DC vaccination-mediated antitumor activity.
Main Results:
- Bidirectional cross-talk between NK cells and DCs enhances the activation and antitumor activity of both cell types.
- NK cells may play a significant, yet underappreciated, role in the efficacy of DC vaccination.
- T-cell responses alone are insufficient to predict clinical outcomes in many DC-vaccinated patients.
Conclusions:
- Natural killer cells could be crucial mediators of therapeutic benefit in dendritic cell vaccination.
- Simultaneous assessment of NK cell and T-cell responses may provide a more accurate prediction of clinical outcomes.
- Further research into NK cell dynamics post-DC vaccination is warranted to optimize cancer immunotherapy.
More Related Videos
11:48Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent In Vitro Activation with Tumor Immune Complexes
Published on: May 31, 2018
10:35Chemical Conjugation of a Purified DEC-205-Directed Antibody with Full-Length Protein for Targeting Mouse Dendritic Cells In Vitro and In Vivo
Published on: February 5, 2021
Related Concept Videos
01:27Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
01:28Cells of the Innate Immune Response
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
01:25Immune Surveillance by NK Cells and Phagocytes
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
01:29Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
01:30Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
01:27Tumor Immunotherapy